Information Links
Mims
Main Navigation
Drugs
Conditions
News and resources
MIMS Free education
Latest MIMS news
.jpg)
Drug information trackers
Drug shortages - live tracker
Use our constantly updated shortages tracker to check...
New products - live tracker
See the latest products added to MIMS with our live...
New generics - live tracker
See the latest generic drugs added to MIMS with our...
Drug price changes - live tracker
Use our constantly updated tracker to follow price...
New and deleted indications - live tracker
See the latest changes to product indications in MIMS...
Products coming soon - live tracker
Monitor forthcoming UK drug launches with our live...
Deleted products - live tracker
See the latest products removed from the UK market...
Most popular
HRT patch and several inhalers to be discontinued in 2026
An estradiol-only patch and several inhalers — including...
First new cough treatment in 50 years available for NHS prescribing
Gefapixant is now available for NHS prescribing, although...
High-dose Wegovy approved to treat obesity
Patients with obesity using Wegovy (semaglutide) for...
Steps taken to resolve aspirin supply disruption
To preserve aspirin supplies, the DHSC has ruled that...
Migraine undertreatment and overprescribing revealed in care paradox
Almost two-thirds of migraine patients are not receiving...
Chewable, prolonged-release methylphenidate tablets launched for ADHD
Tuzulby provides slow-release methylphenidate in chewable...
MIMS Connect
Promoted
Alternative to daily antibiotic prophylaxis recommended by NICE for recurrent UTI
Sponsored by Viatris
Latest NICE NG112 guidelines for recurrent urinary tract infections (rUTI) advises considering methenamine hippurate as an alternative to daily antibiotic prophylaxis in women, trans men and non-binary people with a female urinary system.
Promoted
Tailored management of acute otitis externa
Sponsored by Aspire Pharma Ltd
Exploring effective and targeted topical treatment for acute otitis externa, a common condition with varying treatment approaches.
MIMS Pharma news
Drug shortages drop to lowest number since March but high-impact issues persist
October has seen the lowest number of ongoing drug...
Tirzepatide and semaglutide equally beneficial in heart failure, study suggests
Tirzepatide and semaglutide provide similar benefits...
MIMS Pharma Market Insight Update, August 2025: Including generic dapaglifozin, updated NICE diabetes guidance, and a new progestogen for HRT
Catch up quickly with our monthly round-up of key developments...
Featured MIMS resources
Table: Inhaler carbon emissions
Carbon footprints of asthma and COPD inhalers.
Guideline: Irritable bowel syndrome
Summary of NICE guidance on IBS.
MIMS Tables
At-a-glance drug comparison charts including dosing and monitoring regimens, available presentations, prices, potential sensitisers and compatible devices.
- ACE inhibitors and angiotensin II antagonists: monitoring in primary care
- ADHD treatments
- Antibiotic treatments in adults, summary of regimens
- Antidepressants, a guide to switching and withdrawing
- Calcium and vitamin D supplements for osteoporosis
- Combination inhalers for the treatment of COPD
- Contraceptives, oral and transdermal preparations
- Direct oral anticoagulants for the prevention of stroke
- Dry eye treatments
- Emergency hormonal contraceptives
- Emollients, potential skin sensitisers as ingredients
- Epilepsy preparations
- Hormone replacement therapy (HRT)
- Influenza vaccines 2025/2026
- Lice and scabies treatments
- Insulin preparations
- Smoking cessation treatment options
- Topical steroids, comparison of potencies and formulations
Click here for full list of tables
MIMS Clinics
Prescribing news and resources for key therapeutic areas, collated by the MIMS editors.